Jefferies Group LLC Sutro Biopharma, Inc. Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.78 - $15.31 $70,836 - $139,397	-9,105 Closed	0 $0
Q4 2021 Sep 21, 2023	BUY	$14.25 - $23.53 $48,450 - $80,002	3,400 New	3,400 $50,000
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $129,746 - $214,240	9,105 New	9,105 $89,000
Q4 2020 Feb 16, 2021	SELL	$10.16 - $23.98 $263,144 - $621,082	-25,900 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$7.44 - $13.15 $192,696 - $340,585	25,900 New	25,900 $260,000

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $140M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.